Portfolio Holdings Detail for ISIN IE00BD8KRH84

Stock Name / Fund	iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	GSPX.LS(GBP) CXE
ETF Ticker	GSPX(GBP) Euronext Amsterdam

Holdings detail for DXCM

Show aggregate DXCM holdings

News associated with DXCM

Implied QQEW Analyst Target Price: $156

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 07:55:44

Friday's ETF with Unusual Volume: QQH

The HCM Defender 100 Index ETF is seeing unusually high volume in afternoon trading Friday, with over 190,000 shares traded versus three month average volume of about 26,000. Shares of QQH were up about 0.6% on the day. Components of that ETF with the highest volume on Friday - 2025-09-19 13:23:32

Nasdaq 100 Movers: DXCM, FTNT

In early trading on Friday, shares of Fortinet topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.7%. Year to date, Fortinet has lost about 11.9% of its value. And the worst performing Nasdaq 100 component thus far on the day is DexCo - 2025-09-19 12:11:42

DexCom, Inc. (NASDAQ:DXCM) Receives $99.89 Consensus Price Target from Brokerages

Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the company, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation, fourteen have given a buy recommendation and three have given a strong buy […] - 2025-09-18 03:01:05

Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside

When it comes to identifying target stocks for investment, compelling prospects may include companies that are undervalued and, simultaneously, expected to appreciate in the future. Of course, timing an investment in one of these firms is notoriously difficult. It may help to lo - 2025-09-14 11:27:00

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 13:38:14

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 12:43:18

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 12:13:06

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 10:36:17

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 08:39:38

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 08:27:13

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 06:09:22

DexCom (NASDAQ:DXCM) Downgraded by Oppenheimer to Market Perform

Oppenheimer cut shares of DexCom (NASDAQ:DXCM – Free Report) from an outperform rating to a market perform rating in a research report sent to investors on Monday, MarketBeat.com reports. Other research analysts have also recently issued research reports about the stock. Argus assumed coverage on shares of DexCom in a research report on Thursday, August […] - 2025-09-09 02:50:44

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-08 22:27:11

DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Recommendation of “Moderate Buy” from Analysts

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have issued a strong buy rating on […] - 2025-08-21 02:41:01

Leerink Partnrs Predicts DexCom’s Q3 Earnings (NASDAQ:DXCM)

DexCom, Inc. (NASDAQ:DXCM – Free Report) – Investment analysts at Leerink Partnrs dropped their Q3 2025 earnings estimates for shares of DexCom in a report released on Wednesday, July 30th. Leerink Partnrs analyst M. Kratky now expects that the medical device company will post earnings of $0.57 per share for the quarter, down from their […] - 2025-08-04 02:46:55

DexCom (DXCM) Q2 Revenue Jumps 15%

Key PointsRevenue (GAAP) rose 15% year-over-year in Q2 2025, easily surpassing expectations and driven by strong U.S. and international growth. - 2025-08-01 01:53:01

Allianz Asset Management GmbH Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM)

Allianz Asset Management GmbH lowered its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 22.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 73,079 shares of the medical device company’s stock after selling 21,698 shares during the period. Allianz Asset […] - 2025-07-29 04:42:53

DexCom (DXCM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

Besides Wall Street's top-and-bottom-line estimates for DexCom (DXCM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025. - 2025-07-29 01:00:16

Private Advisor Group LLC Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM)

Private Advisor Group LLC cut its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 11.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 13,461 shares of the medical device company’s stock after selling 1,688 shares during the period. Private Advisor Group LLC’s holdings in DexCom were worth $919,000 as of its most recent […] - 2025-07-28 05:22:58

HighPoint Advisor Group LLC Has $299,000 Holdings in DexCom, Inc. (NASDAQ:DXCM)

HighPoint Advisor Group LLC cut its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 15.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,196 shares of the medical device company’s stock after selling 749 shares during the quarter. HighPoint Advisor Group LLC’s […] - 2025-07-24 05:51:13

AVLV's Underlying Holdings Imply 10% Gain Potential

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-21 10:15:07

DexCom (NASDAQ:DXCM) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research report report published on Friday. A number of other equities research analysts have also commented on the company. Cfra Research upgraded DexCom to a “hold” rating in a research report on Friday, March […] - 2025-07-21 04:58:50

Morgan Stanley Forecasts Strong Price Appreciation for DexCom (NASDAQ:DXCM) Stock

DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by equities research analysts at Morgan Stanley from $82.00 to $89.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the medical device company’s stock. Morgan Stanley’s price objective would indicate a potential upside […] - 2025-07-17 06:22:53

Cerity Partners LLC Grows Stock Holdings in DexCom, Inc. (NASDAQ:DXCM)

Cerity Partners LLC grew its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 4.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 69,601 shares of the medical device company’s stock after acquiring an additional 2,711 shares during the period. Cerity Partners LLC’s […] - 2025-07-17 05:30:58

DexCom, Inc. (NASDAQ:DXCM) Shares Acquired by Stratos Wealth Partners LTD.

Stratos Wealth Partners LTD. increased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 32.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,428 shares of the medical device company’s stock after buying an additional 845 shares during the quarter. Stratos […] - 2025-07-17 04:58:54

Allworth Financial LP Purchases 1,765 Shares of DexCom, Inc. (NASDAQ:DXCM)

Allworth Financial LP lifted its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 163.3% during the 1st quarter, Holdings Channel reports. The firm owned 2,846 shares of the medical device company’s stock after acquiring an additional 1,765 shares during the period. Allworth Financial LP’s holdings in DexCom were worth $201,000 at the end of […] - 2025-07-16 05:18:51

Nisa Investment Advisors LLC Cuts Stake in DexCom, Inc. (NASDAQ:DXCM)

Nisa Investment Advisors LLC lowered its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 53.9% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 34,228 shares of the medical device company’s stock after selling 40,004 shares during the quarter. Nisa Investment Advisors […] - 2025-07-14 05:50:57

Principal Financial Group Inc. Boosts Holdings in DexCom, Inc. (NASDAQ:DXCM)

Principal Financial Group Inc. lifted its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 804,917 shares of the medical device company’s stock after purchasing an additional 219,965 shares during the […] - 2025-07-07 08:08:45

First Horizon Advisors Inc. Has $108,000 Stock Position in DexCom, Inc. (NASDAQ:DXCM)

First Horizon Advisors Inc. increased its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 25.4% during the 1st quarter, Holdings Channel.com reports. The fund owned 1,582 shares of the medical device company’s stock after acquiring an additional 320 shares during the period. First Horizon Advisors Inc.’s holdings in DexCom were worth $108,000 […] - 2025-07-07 06:19:27

iShares Core S&P 500 UCITS ETF GBP Hedged (Dist) DXCM holdings

Date	Number of DXCM Shares Held	Base Market Value of DXCM Shares	Local Market Value of DXCM Shares	Change in DXCM Shares Held	Change in DXCM Base Value	Current Price per DXCM Share Held	Previous Price per DXCM Share Held
2025-09-18 (Thursday)	927,470	USD 70,283,677	USD 70,283,677	55	USD -607,926	USD 75.78	USD 76.44
2025-09-17 (Wednesday)	927,415	USD 70,891,603	USD 70,891,603	495	USD -64,123	USD 76.44	USD 76.55
2025-09-16 (Tuesday)	926,920	USD 70,955,726	USD 70,955,726	220	USD 915,740	USD 76.55	USD 75.58
2025-09-15 (Monday)	926,700	USD 70,039,986	USD 70,039,986	550	USD -551,167	USD 75.58	USD 76.22
2025-09-12 (Friday)	926,150	USD 70,591,153	USD 70,591,153	165	USD 216,293	USD 76.22	USD 76
2025-09-11 (Thursday)	925,985	USD 70,374,860	USD 70,374,860	275	USD 20,900	USD 76	USD 76
2025-09-10 (Wednesday)	925,710	USD 70,353,960	USD 70,353,960	0	USD -2,221,704	USD 76	USD 78.4
2025-09-09 (Tuesday)	925,710	USD 72,575,664	USD 72,575,664	275	USD 391,734	USD 78.4	USD 78
2025-09-08 (Monday)	925,435	USD 72,183,930	USD 72,183,930

Share Trades of DXCM by Blackrock for IE00BD8KRH84

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-09-18	BUY	55			75.780*		79.04
2025-09-17	BUY	495			76.440*		79.05
2025-09-16	BUY	220			76.550*		79.07
2025-09-15	BUY	550			75.580*		79.09
2025-09-12	BUY	165			76.220*		79.10
2025-09-11	BUY	275			76.000*		79.12
2025-09-09	BUY	275			78.400*		79.15
2025-09-04	SELL	-2,365			80.760*		79.14 Profit of 187,159 on sale
2025-09-02	BUY	1,155			74.300*		79.17
2025-08-12	BUY	165			80.170*		79.16
2025-08-11	BUY	495			77.850*		79.16
2025-08-08	BUY	1,265			78.860*		79.17
2025-08-07	BUY	165			76.400*		79.18
2025-08-01	BUY	990			79.280*		79.18
2025-07-31	BUY	55			80.770*		79.17
2025-07-30	BUY	440			89.060*		79.11
2025-07-29	BUY	55			89.350*		79.04
2025-07-14	BUY	440			85.330*		79.00
2025-07-11	SELL	-110			83.370*		78.97 Profit of 8,687 on sale
2025-07-10	BUY	440			85.460*		78.93
2025-07-09	BUY	440			84.870*		78.89
2025-07-08	BUY	330			83.760*		78.86
2025-07-07	SELL	-1,265			82.940*		78.83 Profit of 99,721 on sale
2025-07-02	SELL	-1,595			83.580*		78.74 Profit of 125,594 on sale
2025-06-30	BUY	935			87.290*		78.68
2025-06-27	BUY	495			86.330*		78.63
2025-06-25	SELL	-110			84.680*		78.54 Profit of 8,640 on sale
2025-06-24	BUY	55			87.570*		78.48
2025-06-23	BUY	1,430			79.840*		78.47
2025-06-20	BUY	9,850			80.000*		78.46
2025-06-18	SELL	-330			81.010*		78.42 Profit of 25,879 on sale
2025-06-13	SELL	-165			81.990*		78.37 Profit of 12,931 on sale
2025-06-12	BUY	165			82.850*		78.34
2025-06-11	BUY	220			82.990*		78.30
2025-06-06	SELL	-275			86.670*		78.13 Profit of 21,486 on sale
2025-06-05	SELL	-165			85.740*		78.07 Profit of 12,882 on sale
2025-06-04	SELL	-220			85.610*		78.01 Profit of 17,162 on sale
2025-06-02	BUY	715			85.510*		77.88
2025-05-30	SELL	-156			85.800*		77.82 Profit of 12,140 on sale
2025-05-29	BUY	55			84.860*		77.76
2025-05-28	SELL	-54			86.980*		77.69 Profit of 4,195 on sale
2025-05-27	BUY	605			85.330*		77.62
2025-05-23	SELL	-1,100			84.510*		77.51 Profit of 85,261 on sale
2025-05-22	SELL	-1,210			84.830*		77.45 Profit of 93,712 on sale
2025-05-21	BUY	55			84.890*		77.39
2025-05-20	BUY	440			87.340*		77.30
2025-05-19	BUY	1,595			86.960*		77.22
2025-05-16	BUY	1,485			85.480*		77.14
2025-05-15	BUY	1,210			85.670*		77.07
2025-05-14	BUY	1,100			86.520*		76.99
2025-05-13	SELL	-220			84.110*		76.92 Profit of 16,923 on sale
2025-05-12	BUY	55			85.050*		76.85
2025-05-09	BUY	165			84.670*		76.78
2025-05-08	SELL	-1,595			85.340*		76.70 Profit of 122,337 on sale
2025-05-07	SELL	-770			83.350*		76.64 Profit of 59,012 on sale
2025-05-06	BUY	1,925			81.530*		76.59
2025-05-02	BUY	165			81.620*		76.51
2025-05-01	SELL	-275			70.260*		76.57 Profit of 21,057 on sale
2025-04-30	BUY	165			71.380*		76.62
2025-04-29	BUY	385			71.300*		76.67
2025-04-28	BUY	806			71.180*		76.73
2025-04-25	BUY	756			71.660*		76.78
2025-04-24	BUY	216			70.780*		76.84
2025-04-23	BUY	594			66.860*		76.94
2025-04-22	SELL	-328			66.330*		77.05 Profit of 25,272 on sale
2025-04-17	BUY	108			68.570*		77.35
2025-04-16	BUY	220			68.730*		77.44
2025-04-15	BUY	1,100			69.230*		77.53
2025-04-11	BUY	1,375			66.140*		77.77
2025-04-10	BUY	2,255			67.300*		77.88
2025-04-09	BUY	440			66.840*		78.01
2025-04-08	BUY	1,155			60.690*		78.21
2025-04-07	BUY	1,317			61.630*		78.40
2025-04-04	SELL	-3,300			59.830*		78.62 Profit of 259,448 on sale
2025-04-02	BUY	385			68.140*		78.75
2025-03-31	SELL	-1,458			68.290*		79.01 Profit of 115,200 on sale
2025-03-28	SELL	-918			67.740*		79.15 Profit of 72,661 on sale
2025-03-27	SELL	-270			69.470*		79.27 Profit of 21,404 on sale
2025-03-26	BUY	486			72.130*		79.36
2025-03-25	SELL	-648			73.550*		79.44 Profit of 51,475 on sale
2025-03-24	BUY	378			75.320*		79.49
2025-03-21	BUY	648			73.800*		79.57
2025-03-19	BUY	102			73.380*		79.71
2025-03-18	SELL	-990			70.700*		79.83 Profit of 79,035 on sale
2025-03-17	BUY	1,045			71.350*		79.95
2025-03-14	BUY	935			70.690*		80.08
2025-03-13	BUY	4,612			68.480*		80.25
2025-03-12	BUY	2,200			70.760*		80.38
2025-03-11	BUY	880			70.260*		80.53
2025-03-07	BUY	514			77.840*		80.72
2025-03-06	SELL	-495			79.510*		80.74 Profit of 39,967 on sale
2025-03-05	BUY	1,713			81.960*		80.72
2025-03-04	BUY	330			82.420*		80.70
2025-03-03	BUY	1,485			85.990*		80.61
2025-02-28	SELL	-378			88.370*		80.48 Profit of 30,422 on sale
2025-02-27	BUY	54			87.810*		80.36
2025-02-26	SELL	-108			89.910*		80.20 Profit of 8,661 on sale
2025-02-25	BUY	1,026			88.320*		80.06
2025-02-21	BUY	756			88.780*		79.71
2025-02-20	BUY	432			89.340*		79.54
2025-02-19	BUY	108			89.680*		79.35
2025-02-18	BUY	270			90.530*		79.14
2025-02-13	BUY	918			84.090*		78.64
2025-02-12	BUY	324			83.870*		78.54
2025-02-11	SELL	-108			86.380*		78.37 Profit of 8,464 on sale
2025-02-07	SELL	-432			88.080*		77.95 Profit of 33,673 on sale
2025-02-06	BUY	216			88.320*		77.72
2025-02-04	BUY	1,890			87.460*		77.23
2025-02-03	BUY	702			87.050*		77.00
2025-01-31	BUY	162			86.830*		76.76
2025-01-30	BUY	108			87.620*		76.49
2025-01-29	BUY	1,026			86.430*		76.23
2025-01-28	BUY	486			88.350*		75.91
2025-01-27	BUY	756			87.530*		75.60
2025-01-24	BUY	486			88.750*		75.23
2025-01-23	BUY	1,404			87.700*		74.88
2025-01-22	BUY	918			87.090*		74.52
2024-12-10	BUY	392			79.410*		74.37
2024-12-09	BUY	448			78.410*		74.24
2024-12-06	BUY	672			77.720*		74.13
2024-12-05	BUY	168			78.920*		73.97
2024-12-04	BUY	616			81.010*		73.73
2024-12-03	BUY	1,978			80.910*		73.47
2024-12-02	BUY	164			79.310*		73.26
2024-11-29	BUY	1,265			77.990*		73.07
2024-11-27	BUY	1,485			78.100*		72.65
2024-11-26	BUY	3,190			77.940*		72.42
2024-11-25	BUY	3,300			77.830*		72.18
2024-11-22	BUY	3,920			72.830*		72.15
2024-11-21	BUY	616			74.460*		72.03
2024-11-20	BUY	550			75.240*		71.86
2024-11-19	BUY	495			74.880*		71.70
2024-11-18	BUY	4,455			76.270*		71.43
2024-11-12	BUY	1,540			74.340*		71.25
2024-11-11	BUY	1,045			70.310*		71.31
2024-11-08	BUY	786			69.960*		71.40
2024-11-07	BUY	4,895			68.910*		71.60
2024-11-06	BUY	1,485			68.610*		71.84
2024-11-05	BUY	2,192			69.000*		72.10
2024-11-04	BUY	385			69.700*		72.34
2024-11-01	BUY	880			70.350*		72.56
2024-10-31	BUY	224			70.480*		72.83
2024-10-30	BUY	555			71.800*		72.97
2024-10-29	BUY	1,344			72.240*		73.09
2024-10-28	SELL	-392			72.100*		73.29 Profit of 28,730 on sale
2024-10-25	BUY	672			73.440*		73.26
2024-10-24	BUY	448			74.850*		72.72
2024-10-23	BUY	560			72.480*		72.85
2024-10-22	BUY	1,443			73.080*		72.61
2024-10-21	BUY	1,568			72.610*		0.00

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of DXCM

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer